MYCN protein stability is a better prognostic indicator in neuroblastoma
Cited by 10
Related Papers
Absence of cyclin-dependent kinase inhibitor p27 or p18 increases efficiency of iPSC generation without induction of iPSC genomic instability
|Cell Death and Disease|2019|16
KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA m6A reader YTHDC1 protein degradation
|Journal of Experimental & Clinical Cancer Research|2024|11
Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity
|Cellular Oncology|2022|9
c-Myc alone is enough to reprogram fibroblasts into functional macrophages
|Journal of Hematology & Oncology|2024|3